A bill for an act relating to manufacturers and distributors of 340B drugs.
Subcommittee: Sweeney, Knox, and Warme. S.J. 314.
Email me when SF 2312 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track SF 2312. By continuing you agree to the Terms and Privacy Policy.
Summary
The bill defines “340B drug,” “manufacturer,” and “distributor,” then bars manufacturers or distributors from denying or restricting a covered entity’s acquisition of a 340B drug or its delivery to a contract pharmacy, unless the U.S. Department of Health and Human Services expressly prohibits it. It is intended to safeguard the ability of safety‑net providers to obtain discounted medicines. The measure is currently referred to a Senate subcommittee.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about SF 2312
3 free questions a day, no accountHistory
- Subcommittee: Sweeney, Knox, and Warme.
- Introduced, referred to Commerce.
Sponsors
- SWEENEY · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when SF 2312 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track SF 2312 freeOr ask your AI assistant about SF 2312 directly:
Add to Claude, ChatGPT or Cursor